Zoladex prostate cancer drug

Zoladex prostate cancer drug

C011/6714 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 2.2MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only

Caption: Zoladex prostate cancer drug. Nurse holding a box containing a syringe pre-filled with a Zoladex pellet. The pellet is inserted into the patient's abdomen and releases a controlled amount of the active drug over a set period of time. Zoladex is an LHRH (luteinising hormone-releasing hormone) blocker that is used to treat prostate cancer. It acts on the pituitary gland in the brain to prevent it producing luteinising hormone, the hormone that tells the testes to produce testosterone. In prostate tumours that are sensitive to testosterone, this causes the tumour to shrink. It does not provide a cure, but does increase life expectancy.

Release details: Model release available. Property release not available.

Keywords: adult, andrological, andrology, box, boxed, caucasian, chemotherapy, close-up, condition, detail, disease, disorder, drug, female, gonadorelin, goserelin acetate, healthcare, holding, hormonal, hormonal therapy, hormone, human, implant, injection, male, male reproductive system, medical, medicine, nurse, oncological, oncology, packaging, pellet, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prostate cancer, syringe, testosterone level, treat, treatment, urological, urology, white, woman, zoladex

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.